Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.052 | 0.4 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |